About Us
Team Members
Dr. Lynn joined UBI Group in 1999 as the first scientist to participate in the humanized antibody platform. He led the R&D team in establishing a monoclonal antibody drug development platform, advancing key processes such as antibody humanization, high-expression cell line construction, and process development, successfully moving candidate drugs from early-stage development into clinical trials.In terms of corporate operations, Dr. Lin was responsible for business unit spin-offs and successfully achieved multiple fundraising goals. During his tenure at United Biomedical, Inc. (UBI Asia) and United BioPharma, he raised nearly USD 200 million for the group and led his team to advance three innovative monoclonal antibody products into Phase III, Phase II, and Phase I clinical trials, respectively.
Genesis Life Science WeChat
Genesis Life Science LinkedIn
ZipCode:222500
Tel.:(0514)82222527
Headquarters (Yangzhou): No.2 Jiankang 1st Road, Yangzhou Hi-Tech Zone,
Hanjiang District, Yangzhou City, Jiangsu Province
Team Members
Research Achievement